JP2025519475A5 - - Google Patents

Info

Publication number
JP2025519475A5
JP2025519475A5 JP2024572034A JP2024572034A JP2025519475A5 JP 2025519475 A5 JP2025519475 A5 JP 2025519475A5 JP 2024572034 A JP2024572034 A JP 2024572034A JP 2024572034 A JP2024572034 A JP 2024572034A JP 2025519475 A5 JP2025519475 A5 JP 2025519475A5
Authority
JP
Japan
Application number
JP2024572034A
Other languages
Japanese (ja)
Other versions
JPWO2023239290A5 (https=
JP2025519475A (ja
Filing date
Publication date
Priority claimed from CN202210626787.7A external-priority patent/CN117209588A/zh
Application filed filed Critical
Publication of JP2025519475A publication Critical patent/JP2025519475A/ja
Publication of JPWO2023239290A5 publication Critical patent/JPWO2023239290A5/ja
Publication of JP2025519475A5 publication Critical patent/JP2025519475A5/ja
Pending legal-status Critical Current

Links

JP2024572034A 2022-06-05 2022-12-08 Hbv表面抗原特異的t細胞受容体およびその使用 Pending JP2025519475A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202210626787.7 2022-06-05
CN202210626787.7A CN117209588A (zh) 2022-06-05 2022-06-05 乙肝表面抗原特异性t细胞受体及其用途
PCT/SG2022/050892 WO2023239290A1 (en) 2022-06-05 2022-12-08 Hbv surface antigen specific t cell receptors and uses thereof

Publications (3)

Publication Number Publication Date
JP2025519475A JP2025519475A (ja) 2025-06-26
JPWO2023239290A5 JPWO2023239290A5 (https=) 2025-12-11
JP2025519475A5 true JP2025519475A5 (https=) 2025-12-11

Family

ID=89039487

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024572034A Pending JP2025519475A (ja) 2022-06-05 2022-12-08 Hbv表面抗原特異的t細胞受容体およびその使用

Country Status (9)

Country Link
US (1) US20260021140A1 (https=)
EP (1) EP4536695A1 (https=)
JP (1) JP2025519475A (https=)
KR (1) KR20250031233A (https=)
CN (1) CN117209588A (https=)
AU (1) AU2022462612A1 (https=)
CA (1) CA3258313A1 (https=)
IL (1) IL317429A (https=)
WO (1) WO2023239290A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11214603B2 (en) * 2016-04-27 2022-01-04 The Regents Of The University Of Michigan C3D cellular and acellular vaccines for the prevention and treatment of cancer
CN117624340B (zh) * 2024-01-23 2024-04-30 北京臻知医学科技有限责任公司 识别人乙型肝炎病毒(hbv)抗原的t细胞受体(tcr)及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107827959B (zh) * 2017-11-09 2018-10-30 杭州续缓生物科技有限公司 识别乙肝病毒(hbv)表面抗原s183-91表位的tcr及其用途

Similar Documents

Publication Publication Date Title
JP2025519475A5 (https=)
BR102022025291A2 (https=)
CL2025003047A1 (es) Composición modificadora de matrices poliméricas, con propiedades anticorrosivas, biocidas y mejorador de propiedades mecánicas
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023010976A2 (https=)
BR102023009641A2 (https=)
BR102023008688A2 (https=)
BR102023007252A2 (https=)
BR102023005164A2 (https=)
BR102023001877A2 (https=)
BR102023000289A2 (https=)
BR102022026909A2 (https=)
BR102022023461A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
CN307049382S (https=)
BY13163U (https=)
BY13167U (https=)
BY13174U (https=)
BY13175U (https=)
BY13176U (https=)
BY23963C1 (https=)